Shanghai, China Howbuy is the famous Corporate Investor, which was founded in 2007. The company was established in Asia in China. The main office of represented Corporate Investor is situated in the Shanghai.
The fund is constantly included in less than 2 investment rounds annually. Deals in the range of 10 - 50 millions dollars are the general things for fund. The high activity for fund was in 2018.
Among the various public portfolio startups of the fund, we may underline Lixiangjia Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. For fund there is a match between the location of its establishment and the land of its numerous investments - China. Among the most popular fund investment industries, there are Financial Services, FinTech.
This organization was formed by Ben Yang, Wenbin Yang.
The typical case for the fund is to invest in rounds with 5 participants. The meaningful sponsors for the fund in investment in the same round are Visas Consulting Group, LB Investment, InnoVen Capital.
| Fund Name | Location |
| 1Can Network | - |
| Alloy Online | New York, New York, United States |
| Banca Etica | - |
| BDT Capital Partners | Chicago, Illinois, United States |
| Caltrop | California, Riverside, United States |
| Edap 2007 | Barcelona, Catalonia, Spain |
| Fuji Electronics | Japan, Tokyo |
| G7 | Beijing, Beijing, China |
| Harrison Metal | California, San Francisco, United States |
| HY Capital | Changning, China, Shanghai |
| Jinx Development, LLC | - |
| Lion Capital Partners | New York, New York, United States |
| Metropolis Venture Partners | New York, New York, United States |
| Origin Capital | England, London, United Kingdom |
| Samsung NEXT | California, Mountain View, United States |
| Shanghai Tianji Investment | China, Shanghai |
| The FR Group | British Columbia, Canada, Vancouver |
| Veritas Investment GmbH | Frankfurt, Germany, Hessen |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Tripod Preclinical Research Laboratories | $5M | 12 Apr 2023 | Nanjing, Jiangsu, China | ||
Lixiangjia | $17M | 19 Dec 2018 | China, Beijing | ||
AOW | $463K | 15 Apr 2015 | Shanghai, China |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Tripod Preclinical Research Laboratories | $5M | 12 Apr 2023 | Nanjing, Jiangsu, China | ||
Lixiangjia | $17M | 19 Dec 2018 | China, Beijing | ||
AOW | $463K | 15 Apr 2015 | Shanghai, China |
